Find a
  WATCHMAN  
Implanter

WATCHMAN DELIVERS POSITIVE RESULTS IN CLINICAL TRIALS


  • The WATCHMAN Implant has been proven to offer stroke risk reduction comparable to warfarin—and also reduces the long-term risk of bleeding associated with warfarin use
  • WATCHMAN demonstrated statistically superior reductions in the risk of cardiovascular death, hemorrhagic stroke, and all-cause mortality vs warfarin after 4 years of follow-up in the PROTECT AF study1

PROVEN PROCEDURE


Learn about the efficacy results of WATCHMAN compared to warfarin in clinical trials of patients with non-valvular atrial fibrillation (NVAF) who have a reason to seek an alternative to OACs

PROVEN SAFETY


Review safety data from the clinical studies as well as real-world results from the initial US commercial experience, showing overall high implant success rates for WATCHMAN.

 

Follow Us: Twitter LinkedIn YouTube Google+
Top